MDMA, Screen and Confirmation, Urine
Use
Detect and confirm the presence of MDMA (methylenedioxymethamphetamine)
Special Instructions
The test is primarily intended for usage in pain management settings. It does not fulfill the requirements for workplace drug testing programs under state regulations.
Limitations
This test should not be used for workplace drug testing as it does not meet state regulatory requirements for such purposes. Additionally, the presence of MDMA and its metabolites can only be confirmed if the specimen is handled and stored correctly to prevent degradation or contamination.
Methodology
Immunoassay (CLIA)
Biomarkers
LOINC Codes
- 19568-5
- 73971-4
- 19565-1
- 20545-0
- 18358-2
- 59844-1
- 45143-5
- 77202-0
Result Turnaround Time
1-5 days
Related Documents
For more information, please review the documents below
Specimen
Urine
Volume
20 mL
Minimum Volume
Not provided
Container
Plastic urine container
Storage Instructions
Maintain specimen at room temperature. If arrival at lab will extend beyond seven days, refrigerate.
Other tests from different labs that may be relevant